CO-DIAGNOSTICS INC's ticker is CODX and the CUSIP is 189763105. A total of 74 filers reported holding CO-DIAGNOSTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532,870 | -5.2% | 502,708 | -0.8% | 0.00% | – |
| Q2 2023 | $562,225 | -24.3% | 506,509 | +1.0% | 0.00% | – |
| Q1 2023 | $742,378 | -45.4% | 501,607 | -7.0% | 0.00% | – |
| Q4 2022 | $1,358,611 | -21.6% | 539,131 | -0.1% | 0.00% | – |
| Q3 2022 | $1,732,000 | -38.5% | 539,595 | +7.6% | 0.00% | – |
| Q2 2022 | $2,814,000 | -6.6% | 501,642 | +2.9% | 0.00% | – |
| Q1 2022 | $3,013,000 | -31.2% | 487,478 | -0.6% | 0.00% | – |
| Q4 2021 | $4,380,000 | -15.3% | 490,446 | -7.7% | 0.00% | – |
| Q3 2021 | $5,169,000 | +21.0% | 531,266 | +2.6% | 0.00% | – |
| Q2 2021 | $4,273,000 | -77.1% | 517,938 | -73.5% | 0.00% | -100.0% |
| Q1 2021 | $18,652,000 | +4.4% | 1,955,074 | +1.7% | 0.00% | 0.0% |
| Q4 2020 | $17,871,000 | -27.0% | 1,921,670 | +6.6% | 0.00% | 0.0% |
| Q3 2020 | $24,489,000 | -29.8% | 1,801,909 | +0.0% | 0.00% | 0.0% |
| Q2 2020 | $34,863,000 | +1162000.0% | 1,801,790 | +138605.9% | 0.00% | – |
| Q1 2018 | $3,000 | – | 1,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Koss-Olinger Consulting, LLC | 111,808 | $119,000 | 0.02% |
| Physician Wealth Advisors, Inc. | 39,375 | $40,950 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 272,900 | $289,274 | 0.01% |
| Aristides Capital LLC | 15,000 | $15,900 | 0.01% |
| XTX Topco Ltd | 21,763 | $23,069 | 0.00% |
| Portside Wealth Group, LLC | 12,000 | $13,000 | 0.00% |
| Engineers Gate Manager LP | 13,309 | $14,108 | 0.00% |
| Renaissance Technologies | 636,400 | $675 | 0.00% |
| Kestra Advisory Services, LLC | 128,560 | $136,274 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 4,000 | $4,240 | 0.00% |